| 查看: 886 | 回复: 6 | |||||||||
| 当前只显示满足指定条件的回帖，点击这里查看本话题的所有回帖 | |||||||||
[交流]
【2014-10-31】Pulsus出版集团当代医学论坛 & 征稿（通知）
|
|||||||||
Call for Papers Current Oncology (www.current-oncology.com) Current Oncology is a peer-reviewed, Canadian based and internationally respected journal, indexed by Science Citation Index (SCI) with an Impact Factor (IF) of 1.473 (2013 Journal Citation Reports, Science Edition). Published bi-monthly, plus special supplemental issues, Current Oncology represents a multidisciplinary medium encompassing health care workers in the field of cancer therapy to report upon and to review progress in the management of this disease. The journal publishes a range of article types that encompass all aspects of cancer medicine: Original articles, Review articles, Commentaries, Practice guidelines, Letters to the Editor Perspectives, Short communications and Case reports. Manuscripts must be solely the work of the author(s) stated, must not have been previously published elsewhere, and must not be under consideration by another journal. Articles published in the journal contain information that is relevant directly to clinical oncology practice, and have clear potential for application to the current or future practice of cancer medicine. Current Oncology aims to facilitate the communication from the laboratory to the bedside; contributing to cancer prevention, treatment, early detection, diagnosis, survivorship and rehabilitation. All papers should be written to be clearly understandable to the journal’s readers in a wide range of specialties. Submissions in the area of basic research are not accepted by the journal. In 2012, the journal had over 250 submissions and an article acceptance rate of 57%. Articles submitted to the journal undergo our rigorous peer review process and must be accepted prior to publication. For further information about our peer review policy, please visit https://www.current-oncology.com ... issions#PeerReview. Benefits of Publishing with Current Oncology include: • Articles are freely and permanently accessible online immediately upon publication 相关信息访问中文网站 “朋博学者网”通知 https://www.medicinepub.com/inde ... tid=3&id=22 [ Last edited by Paulwolf on 2014-11-19 at 05:50 ] |
回复此楼» 猜你喜欢
关于filecode，很负责任的告诉大家
已经有7人回复
-
【2027博士申请】纳米药物递送方向
已经有5人回复
-
关于豆爷回答的JTJC与%2F数量
已经有7人回复
-
2026国自然放榜时间
已经有3人回复
-
国基金的申报应该改成非等额制，评价高的钱多评价低的钱少，但是增加资助率
已经有7人回复
-
好奇怪的filecode
已经有4人回复
-
售SCI文章，我:8O5.5.1.O.54,科目齐全,可+急
已经有4人回复
-
售SCI一区T0P文章，我:8.O.55.1.O54,科目全,可伽急
已经有4人回复
-
售SCI文章，我:8O.5.5.1O.54,科目全,可十急
已经有4人回复
-
售SCI一区T0P文章，我:8.O.55.1.O.54,科目齐全,可+急
已经有5人回复
» 抢金币啦！回帖就可以得到:
-
中科院招聘博士后及科研助理
+2/220
-
山东征女友，坐标济南
+1/158
-
别研究filecode了，祝都有一个好结果：）
+2/94
-
三(三甲基硅基)硼酸酯（CAS：4325-85-3）
+1/87
-
乙二醇二甲基环硅醚（CAS：57915-66-9）
+1/87
-
1,3,2-Dioxaphospholane, 2-(2,2,3,3,3-pentafluoropropoxy)-
+1/86
-
2-氯-1,3,2-二氧磷杂环戊烷（CAS：822-39-9）
+1/86
-
1,2-双(三甲基硅氧基)苯（CAS：5075-52-5）
+1/85
-
四(三甲基硅基)赤藓醇醚（CAS：18547-29-0 ）
+1/81
-
上海交通大学诚聘有机化学方向博士生/科研助理
+1/29
-
哈工大（深圳）何自开团队诚招化学工程与技术专业博士生
+1/27
-
北京理工大学-集成电路与电子学院杰青团队-招博士后
+1/24
-
双一流高校招收博士（现代技术管理/环境技术经济管理）及硕士研究生（长期有效）
+1/13
-
澳大利亚 Murdoch University 全奖博士招生（3个名额）地质化工冶金领域
+1/10
-
有合作举办scopus会议的吗？
+1/5
-
香港理工大学殷骏课题组诚聘1 名博士后以及2 名博士生
+1/4
-
夏尽秋来，蓄力沉淀，静待硕果成文
+1/4
-
COMSOL鼓泡塔模拟液相消失求助
+1/4
-
北理工集成电路杰青团队 | 诚招科助理
+1/2
-
北理工集成电路杰青团队 | 诚招科助理
+1/2
7楼2014-10-20 15:22:51
简单回复
yuguiyan3楼
2014-10-19 21:27
回复
xmh880523(金币+1): 谢谢参与
， [ 发自小木虫客户端 ]
大内总管5楼
2014-10-19 21:33
回复
xmh880523(金币+1): 谢谢参与
